Bausch Health Companies Inc. (BHC)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Bausch Health Companies Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Bausch Health Companies Inc. (BHC) has returned -22.30% so far this year and -16.54% over the past 12 months. Over the last ten years, BHC has returned -15.21% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Jan 2, 2001, BHC's average daily return is +0.04%, while the average monthly return is +0.74%. At this rate, your investment would double in approximately 7.8 years.

Historically, 53% of months were positive and 47% were negative. The best month was Jun 2025 with a return of +47.0%, while the worst month was Mar 2016 at -60.0%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, BHC closed higher 49% of trading days. The best single day was Nov 1, 2016 with a return of +33.7%, while the worst single day was Mar 15, 2016 at -51.5%.

Bausch Health Companies Inc. has an annualized alpha of 0.47%, beta of 1.03, and R² of 0.14 versus S&P 500 Index. Calculated based on daily prices since January 03, 2001.

• This stock participated in 121.62% of S&P 500 Index downside but only 66.13% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.14 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BHC ranks 28 for risk / return — below 28% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Bausch Health Companies Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bausch Health Companies Inc. was 98.35%, occurring on Apr 11, 2025. The portfolio has not yet recovered.

The current Bausch Health Companies Inc. drawdown is 97.94%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Bausch Health Companies Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Bausch Health Companies Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.